News

I was 21 and the message couldn't have been clearer: it was all downhill for me now. I'd soon look like an old lady. Much ...
Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...
Apogee Therapeutics shares crumbled Monday despite promising results for what could become a quarterly or twice-yearly shot ...
Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...
Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...
Shares of Apogee Therapeutics Inc. (NASDAQ:APGE) soared 24% in Monday’s session following encouraging results from its Phase ...